Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Retinoic acid signaling is essential for airway smooth muscle homeostasis
Felicia Chen, … , Ramaswamy Krishnan, Alan Fine
Felicia Chen, … , Ramaswamy Krishnan, Alan Fine
Published August 23, 2018
Citation Information: JCI Insight. 2018;3(16):e120398. https://doi.org/10.1172/jci.insight.120398.
View: Text | PDF
Research Article Pulmonology

Retinoic acid signaling is essential for airway smooth muscle homeostasis

  • Text
  • PDF
Abstract

Airway smooth muscle (ASM) is a dynamic and complex tissue involved in regulation of bronchomotor tone, but the molecular events essential for the maintenance of ASM homeostasis are not well understood. Observational and genome-wide association studies in humans have linked airway function to the nutritional status of vitamin A and its bioactive metabolite retinoic acid (RA). Here, we provide evidence that ongoing RA signaling is critical for the regulation of adult ASM phenotype. By using dietary, pharmacologic, and genetic models in mice and humans, we show that (a) RA signaling is active in adult ASM in the normal lung, (b) RA-deficient ASM cells are hypertrophic, hypercontractile, profibrotic, but not hyperproliferative, (c) TGF-β signaling, known to cause ASM hypertrophy and airway fibrosis in human obstructive lung diseases, is hyperactivated in RA-deficient ASM, (d) pharmacologic and genetic inhibition of the TGF-β activity in ASM prevents the development of the aberrant phenotype induced by RA deficiency, and (e) the consequences of transient RA deficiency in ASM are long-lasting. These results indicate that RA signaling actively maintains adult ASM homeostasis, and disruption of RA signaling leads to aberrant ASM phenotypes similar to those seen in human chronic airway diseases such as asthma.

Authors

Felicia Chen, Fengzhi Shao, Anne Hinds, Sean Yao, Sumati Ram-Mohan, Timothy A. Norman, Ramaswamy Krishnan, Alan Fine

×

Figure 6

Deletion of TGF-β receptor 2 (Tgfbr2) in mouse smooth muscle in vivo prevents the increase in Col1a2 expression, ASM layer thickness, and airway responsiveness induced by BMS.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of TGF-β receptor 2 (Tgfbr2) in mouse smooth muscle in vivo pre...
Myh11-CreERT2;Tgfbr2fl/fl transgenic mice were injected with tamoxifen to delete TGF-β receptor 2 (Tgfbr2) in the smooth muscle and then given 5 days of CTR or BMS diet (TAM-CTR, TAM-BMS). Corn oil–injected littermates with the same genotype with 5 days of CTR and BMS were used as control (OIL-CTR, OIL-BMS). (A–D) Immunostaining of phospho-SMAD2 (p-SMAD2) showing signals within the ASM layer of OIL-BMS (B) but not in OIL-CTR (A) airways, similar to what is observed in CTR and BMS airways in WT mice. Scale bar: 20 μm. Deletion of Tgfbr2 in smooth muscle eliminates p-SMAD2 signals in TAM-CTR (C) and TAM-BMS (D) airways (n = 3 per group). Yellow lines delineate the margin of the ASM layer. (E) Morphometric analysis showing a thicker ASM layer in OIL-BMS airways compared with OIL-CTR airways. There was no significant difference in the thickness of the ASM layer among OIL-CTR, TAM-CTR, and TAM-BMS airways (n = 3 mice per group; 8–9 airways per mouse). (F) Airway resistance (Res) is higher in the OIL-BMS group at baseline and with methacholine (MeCh) challenge compared with OIL-CTR, TAM-CTR, and TAM-BMS. There is no significant difference in airway responsiveness between OIL-CTR, TAM-CTR, and TAM-BMS mice (n = 6 per group). Data represent the mean ± SEM (E) or mean ± range (F). Two-way ANOVA was used for statistical analysis. Bonferroni’s correction for multiple comparisons was applied to adjust P values. *P < 0.05, n.s., P ≥ 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts